+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
Esophageal Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Esophageal Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 269 Pages
  • Global
From
From
Oral Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Oral Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 279 Pages
  • Global
From
From
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 380 Pages
  • Global
From
From
Retinoblastoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Retinoblastoma Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 279 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 371 Pages
  • Global
From
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 377 Pages
  • Global
From
Nasopharyngeal Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Nasopharyngeal Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 288 Pages
  • Global
From
Personalized Cancer Medicines - Global Strategic Business Report - Product Thumbnail Image

Personalized Cancer Medicines - Global Strategic Business Report

  • Report
  • November 2025
  • 267 Pages
  • Global
From
Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 462 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • November 2025
  • 211 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 193 Pages
  • Global
From
Immune Checkpoint Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Immune Checkpoint Inhibitors - Global Strategic Business Report

  • Report
  • November 2025
  • 194 Pages
  • Global
From
From
Loading Indicator